Pediatrix Medical Group, Inc. (MD) stock
MDNYSEServices-HospitalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/307% above fair value
$31.40−0.05 (-0.16%)
Close on Nov 12, 2026Market cap $2.45BP/E 17.1Yield –
Pediatrix Medical statistics
91 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 18, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/OCF Ratio
- 10.81
- 14.89
Enterprise valuationIndustry
- EV / Sales
- 1.33
- 1.67
- EV / EBIT
- 12.25
- 20.39
Share statisticsIndustry
- Shares Change (YoY)
- -3.22%
- 2.40%
- Shares Change (QoQ)
- -3.85%
- 0.33%
- Float
- 77M
- 35M
- Shares Held by Insiders
- 1.49%
- 15.2%
- Shares Held by Institutions
- 107.1%
- 83.6%
Short sellingIndustry
- Short Interest
- 4M
- –
- Short Interest Change
- -18.9%
- -0.86%
- Short % of Float
- 4.61%
- 6.37%
- Short % of Shares Outstanding
- 4.54%
- 4.21%
- Days to Cover
- 5.03
- 4.41
Stock price statisticsIndustry
- 52-Week High
- $33.74
- –
- 52-Week Low
- $17.23
- –
- 20-Day Moving Average
- $29.93
- –
- 50-Day Moving Average
- $27.80
- –
- 200-Day Moving Average
- $24.31
- –
- Average True Range (14)
- $1.11
- –
- Price Change (1 Week)
- -1.38%
- -1.40%
- Price Change (1 Month)
- 16.0%
- 0.09%
- Price Change (3 Months)
- 18.0%
- 2.97%
- Price Change (6 Months)
- 33.7%
- 19.4%
- Price Change (YTD)
- 46.8%
- 6.83%
- Price Change (1 Year)
- 38.9%
- 8.30%
- Price Change (3 Years)
- 243.2%
- 20.9%
- Price Change (5 Years)
- 10.8%
- -13.8%
- Price Change (10 Years)
- -49.0%
- 192.4%
- Average Volume (10 Days)
- 830,973
- –
- Average Volume (20 Days)
- 747,846
- –
- Average Volume (90 Days)
- 760,536
- –
- Relative Volume
- 0.49
- 0.76
- Relative Strength Index (14)
- 66.0
- 47.0
- Volatility (1 Year)
- 35.1%
- 63.0%
- Beta (5 Years)
- 0.67
- 0.77
MarginsIndustry
- Pretax Margin
- 10.4%
- 2.12%
- EBITDA Margin
- 12.1%
- 3.36%
Returns on capitalIndustry
- Return on Equity (ROE)
- 17.2%
- 4.82%
- Return on Assets (ROA)
- 6.92%
- -3.06%
- Return on Invested Capital (ROIC)
- 15.4%
- 4.69%
- Return on Capital Employed (ROCE)
- 13.3%
- 0.40%
Financial positionIndustry
- Current Ratio
- 1.28
- 1.41
- Quick Ratio
- 1.23
- 0.99
- Debt / Equity
- 0.68
- 0.69
- Debt / EBITDA
- 2.44
- 2.57
- Net Debt / EBITDA
- 0.64
- 2.14
- Interest Coverage
- 6.38
- -0.63
GrowthIndustry
- Revenue Growth (YoY)
- 1.91%
- 9.63%
- Net Income Growth (YoY)
- -7.46%
- 16.5%
- EPS Growth (YoY)
- -3.16%
- 19.0%
- Revenue Growth (3Y CAGR)
- -0.99%
- 11.3%
- Revenue Growth (5Y CAGR)
- 1.99%
- 12.6%
- EPS Growth (3Y CAGR)
- 34.9%
- 19.8%
EfficiencyIndustry
- Asset Turnover
- 0.90
- 0.81
- WACC
- 7.49%
- 8.16%
Income statement (TTM)Industry
- Pretax Income
- $203.43M
- -$575.82K
Balance sheetIndustry
- Net Cash (Debt)
- -$151.88M
- $119.40K
- Net Cash Per Share
- -$1.94
- $0.00
- Equity (Book Value)
- $849.62M
- $235.60M
- Book Value Per Share
- $10.88
- $3.91
- Tangible Book Value
- -$431.73M
- $1.59M
- Working Capital
- $148.35M
- $30.06M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- 6.12%
- 0.23%
- Buyback Yield
- 8.49%
- 0.99%
- Shareholder Yield
- 8.49%
- 1.58%
Taxes and interestIndustry
- Interest Expense
- $33.30M
- $7.37M
- Income Tax
- $53.34M
- $564.50K
- Effective Tax Rate
- 26.2%
- 24.1%
Scores and fair valueIndustry
- Graham Number
- $21.22
- $21.25
- Graham Upside
- -32.4%
- -49.9%
- Altman Z-Score
- 2.47
- 2.24
- Piotroski F-Score
- 6
- 5
- Lynch Fair Value
- $46.00
- –
- Lynch Upside
- 46.5%
- -24.2%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | MD | S&P 500 | Difference | MD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +16.6% | -2.7% | +19.3 pts | ||
| 3 months | +18.5% | -1.7% | +20.2 pts | ||
| Year to date | +46.8% | +11.9% | +34.9 pts | ||
| 1 year | +38.4% | +12.0% | +26.4 pts | ||
| 3 years | +240.9% | +78.2% | +162.8 pts | +50.5% | +21.2% |
| 5 years | +10.8% | +73.2% | −62.4 pts | +2.1% | +11.6% |
| 10 years | -49.0% | +309.6% | −358.6 pts | -6.5% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
4M MD shares were sold short on Oct 30, 2026, down 18.9% from the previous report, or 4.61% of the shares available to trade. At recent volumes it would take 5.0 days to buy them back. Over the last 20 sessions, 57.1% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 3,546,600 | -18.9% | 705,586 | 5.0 |
| Oct 15, 2026 | 4,371,489 | -5.2% | 750,346 | 5.8 |
| Sep 30, 2026 | 4,610,228 | -2.5% | 761,576 | 6.0 |
| Sep 15, 2026 | 4,730,174 | -1.8% | 685,069 | 6.9 |
| Aug 31, 2026 | 4,817,490 | -2.5% | 762,513 | 6.3 |
| Aug 14, 2026 | 4,942,920 | +19.4% | 922,389 | 5.4 |
| Jul 31, 2026 | 4,139,091 | -15.7% | 623,866 | 6.6 |
| Jul 15, 2026 | 4,908,297 | +29.0% | 905,748 | 5.4 |
| Jun 30, 2026 | 3,803,637 | +1.1% | 928,286 | 4.1 |
| Jun 15, 2026 | 3,762,756 | +12.0% | 685,438 | 5.5 |
| May 29, 2026 | 3,359,966 | -3.0% | 755,292 | 4.5 |
| May 15, 2026 | 3,463,315 | +1.7% | 1,091,147 | 3.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?